Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host Response and Inflammation

Bartonella henselae-Specific Cell-Mediated Immune Responses Display a Predominantly Th1 Phenotype in Experimentally Infected C57BL/6 Mice

Mardjan Arvand, Ralf Ignatius, Thomas Regnath, Helmut Hahn, Martin E. A. Mielke
Mardjan Arvand
Department of Medical Microbiology, Institute of Infectious Diseases, Free University of Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Ignatius
Department of Medical Microbiology, Institute of Infectious Diseases, Free University of Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Regnath
Department of Medical Microbiology, Institute of Infectious Diseases, Free University of Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helmut Hahn
Department of Medical Microbiology, Institute of Infectious Diseases, Free University of Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin E. A. Mielke
Department of Medical Microbiology, Institute of Infectious Diseases, Free University of Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.10.6427-6433.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Immune responses of the immunocompetent host to Bartonella henselae infection were investigated in the murine infection model using C57BL/6 mice. Following intraperitoneal infection with human-derived B. henselae strain Berlin-1, viable bacteria could be recovered from livers and spleens during the first week postinfection, while Bartonella DNA remained detectable by PCR in the liver for up to 12 weeks after infection. Granulomatous lesions developed in livers of infected mice, reached maximal density at 12 weeks after infection, and persisted for up to 20 weeks, indicating that B. henselae induced a chronic granulomatous hepatitis in the immunocompetent murine host. T-cell-mediated immune responses were analyzed in vitro by means of spleen cell proliferation and cytokine release assays as well as analysis of immunoglobulin G (IgG) isotypes. Spleen cells from infected mice proliferated specifically upon stimulation with heat-killedBartonella antigen. Proliferative responses were mainly mediated by CD4+ T cells, increased during the course of infection, peaked at 8 weeks postinfection, and decreased thereafter. Gamma interferon, but not interleukin-4, was produced in vitro by spleen cells from infected animals upon stimulation withBartonella antigens. Bartonella-specific IgG was detectable in serum of infected mice by 2 weeks, and the antibody concentration peaked at 12 weeks postinfection. IgG2b was the prominent isotype among the Bartonella-specific serum IgG antibodies. These data indicate that B. henselaeinduces cell-mediated immune responses with a Th1 phenotype in immunocompetent C57BL/6 mice.

Clinical presentation of infections caused by Bartonella henselae ranges from a relatively mild lymphadenopathy with few additional symptoms, seen in cat scratch disease (CSD) in immunocompetent patients, to life-threatening systemic disease in immunocompromised individuals, such as bacillary angiomatosis and peliosis (BAP) associated with bacteremia and fever (2). Little is known about the pathogenesis of B. henselae infections and the induced immune responses, mainly because of the lack of a suitable animal model. Several observations point to a crucial role of cell-mediated immunity (CMI) in the pathogenesis and control of B. henselae infections. In human immunodeficiency virus (HIV)-infected patients with AIDS, the clinical manifestations of disease are more severe than the mild and self-limiting course of infection in immunocompetent patients. Recently, Mohle-Boetani et al. (19) reported that HIV-infected individuals with CD4+ T-cell counts of <50 μl−1 are at highest risk for developing BAP and suggested than BAP be considered an AIDS-defining opportunistic infection. Also, B. henselae has been shown to induce granuloma formation in experimentally infected animals (9, 22) and in lymph nodes, spleens, and livers of human patients suffering from CSD (8, 12, 13, 27), indicating the induction of CMI in immunocompetent hosts. In addition, in the era prior to detection of B. henselae and its recognition as the main causative agent of CSD, the induction of a delayed-type hypersensitivity reaction, a hallmark of CMI, was used to diagnose CSD clinically (14).

Cats are considered the natural host of B. henselae and source of infection for humans. There are few reports on experimental infection of cats with B. henselae; however, the course of disease in cats differs from that in humans, and the results for clinical manifestations and histopathological findings are conflicting (7, 9, 11, 21, 23), possibly as a result of using different B. henselae strains and/or different mechanisms of inoculation. In addition, characterization of the induced immune responses has been difficult because of limitations of immunological tools in feline models. In contrast, murine infection models have been shown to be often advantageous for immunological studies (16). In the present study, we used a murine model of B. henselae infection established in our laboratory (22) to investigate the immune responses induced in the immunocompetent host. Following intraperitoneal (i.p.) infection of C57BL/6 mice with B. henselae, the cellular and humoral immune responses were analyzed at multiple time points until 20 weeks postinfection (p.i.). Proliferative responses were studied in vitro by means of a splenocyte proliferation assay. The roles of different T-cell subsets were investigated by administration of monoclonal antibodies (MAbs) to CD4 and CD8 T cells in proliferation assays. In cytokine release studies, Th cells involved in CMI against B. henselae were further characterized. Humoral immune responses were studied by enzyme-linked immunoassay (ELISA) forBartonella-specific immunoglobulin G (IgG) antibodies, and the IgG isotypes were determined. In addition, development and alterations of granulomatous lesions in livers of infected mice were monitored histologically.

The present study demonstrates that a virulent B. henselaestrain is capable of inducing a long-lived inflammation of the liver and strong Th1 type immune responses in immunocompetent C57BL/6 mice.

MATERIALS AND METHODS

Bacteria. B. henselae strain Berlin-1, which was originally isolated from the cutaneous bacillary angiomatosis lesions of an HIV-infected patient (4), was used throughout this study. The primary isolate was inoculated in brucella broth supplemented with 250 mg of hemin/liter and 8% Fildes (24), grown to a log-phase culture, and stored in aliquots at −70°C. To prepare the inocula for the infection, aliquots were thawed and grown again to log-phase cultures in supplemented brucella broth, washed twice with phosphate-buffered saline (PBS), and resuspended in PBS to obtain a final concentration of (2 ± 1) × 108 CFU/ml. One aliquot was plated in 10-fold serial dilutions on Columbia agar with 5% human blood to determine the colony count, and the remaining bacteria were used for inoculation of animals within 1 h after preparation.

Mice.Female C57BL/6 mice raised in our breeding facilities were used at the age of 10 to 13 weeks. Animals were kept under specific-pathogen-free conditions (positive-pressure cabinet).

Infection of animals.Animals were injected i.p. with 1 × 108 to 2 × 108 CFU of B. henselae in a volume of 1 ml of PBS or with 1 ml of PBS as a control. At 1 to 7 days and at 2, 4, 8, 12, and 20 weeks p.i., at least three mice per group were euthanized with CO2 asphyxiation. Livers were collected for histology, culture, and PCR, and spleens were removed aseptically for proliferation and cytokine release assays and culture. Serum samples were collected by standard procedures for serology and were stored at −70°C until used.

Detection of B. henselae by culture and PCR.Bacterial loads in livers and spleens were determined by plating 10-fold serial dilutions of organ homogenates on Columbia agar supplemented with 5% human blood. For the detection ofBartonella DNA, samples of liver tissue (0.1 to 0.2 mg) were snap-frozen in liquid nitrogen and stored at −70°C until used. DNA was isolated by using the QIAamp tissue extraction kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. A seminested PCR assay was performed to amplify part of the htrA gene (1) by using oligonucleotides CAT1 and CAT2 as the outer primers and CAT2 and RH1 as the inner primers (1). PCR was performed with Taq polymerase (In ViTek, Berlin, Germany) in a volume of 50 μl in two sequential tubes. Amplification was accomplished for outer primers by predenaturing for 4 min at 94°C followed by 35 cycles of 94°C for 30 s, 60°C for 60 s, and 72°C for 45 s and a final extension step of 72°C for 10 min. The second amplification step was carried out under the same conditions, except that 45 cycles were performed. Positive and negative controls were included in each run. After electrophoresis through a 2% agarose gel and staining with ethidium bromide, the products were photographed. The presence of a 390-bp band was considered positive. The detection limit of this procedure was 10 CFU per organ.

Histology.One liver lobe per mouse was fixed in 4% (vol/vol) formalin-PBS, embedded in paraffin, sectioned (3 μm thick), and stained with hematoxylin and eosin. Numbers of granulomatous lesions were determined by counting focal mononuclear infiltrations per 0.25 cm2 at ×100 magnification.

Spleen cell proliferation assay.T-cell proliferative responses to Bartonella antigens were studied by [3H]thymidine ([3H]TdR) incorporation. Single-cell suspensions of spleen cells were prepared as follows. Spleens were disrupted in RPMI 1640 (all cell culture products were purchased by Biochrom, Berlin, Germany) supplemented with penicillin (100 U/ml) and streptomycin (100 μg/ml). Erythrocytes were lysed by 60 s of incubation in H2O. Cells were washed twice and resuspended at a density of 107 cells/ml in RPMI 1640 supplemented with 0.2 mM l-glutamine; 100 U of penicillin, 100 μg of streptomycin, and 20 mg of polymyxin B (Sigma, Deisenhofen, Germany)/ml; and 10% heat-inactivated fetal calf serum. The viability of cells was >98% as determined by trypan blue exclusion. Samples of 0.1 ml (106 cells) were added to 0.1 ml of antigen suspension in 96-well flat-bottom tissue culture plates. As the antigen, we used heat-killed (45 min at 60°C) B. henselae(HKBH) at final concentrations of 104 to 107 CFU/ml, concanavalin A (5 μg/ml), pokeweed mitogen (5 μg/ml), or medium only. Experimental conditions were set up in triplicate. Cultures were incubated at 37°C in 5% CO2 for 3 days. This incubation period had been found in preliminary experiments to be appropriate for detection of splenocyte proliferative responses to HKBH. [3H]TdR (1 μCi/well; Amersham, Buckinghamshire, United Kingdom) was added to the wells for the final 18 h of incubation. Cells were then harvested onto glass fiber filters by a semiautomated harvester. Incorporation of [3H]TdR was determined in a liquid scintillation counter. Results were expressed as mean counts per minute for each animal.

In some experiments, blocking MAbs to CD4 or CD8 or an isotype control antibody (Pharmingen, San Diego, Calif.) was added to the wells at a final concentration of 20 μg/ml. Stimulation was performed with 106 CFU of HKBH/ml or with medium only.

For the kinetics studies, stimulation indices (SIs) were calculated to facilitate comparison of the proliferation rates at different time points p.i. by dividing mean counts per minute of HKBH-containing wells (triplicates) by mean counts per minute for medium-only wells (triplicates) for each animal. Stimulation ratios (SR) were then calculated to facilitate comparison among groups by dividing the SI for each infected mouse by the mean SI for three uninfected control mice tested at the same time point (10).

Measurement of cytokine production by spleen cells.The concentrations of gamma interferon (IFN-γ) and interleukin-4 (IL-4) in supernatants of spleen cell cultures were determined using commercially available ELISA kits (Pharmingen) according to the manufacturer's recommendation. Supernatants were collected after 48 h of stimulation of spleen cells with antigens and stored at −40°C until used. Cytokine levels were estimated by comparison with standard curves for recombinant murine IFN-γ and IL-4. The detection limits of the assays were 100 pg/ml for IFN-γ and 150 pg/ml for IL-4.

Determination of Bartonella-specific IgG antibodies.Levels of Bartonella-specific total IgG and IgG subclasses IgG1 and IgG2b were determined in serum by means of ELISA. Microtiter plates were coated overnight at 4°C with outer membrane proteins (OMP) of B. henselae strain Berlin-1 (8a, 25) at a concentration of 10 μg/ml in bicarbonate buffer (0.1 ml/well). Plates were washed and blocked with PBS containing 0.5% Tween 20 (Merck, Darmstadt, Germany) and 0.3% bovine serum albumin (Sigma) for 30 min at 37°C (0.2 ml/well). After three washes, 0.1-ml diluted serum samples were added to the wells and incubated for 30 min at 37°C. For the determination of total IgG, sera were diluted 1:10,000 in PBS-Tween. To analyze the IgG subclasses, fourfold serial dilutions of the sera were performed (1:200 to 1:3,200,000). After three washes, 0.1 ml of rabbit anti-mouse IgG-, IgG1-, or IgG2b-horseradish peroxidase conjugate (Dianova, Hamburg, Germany) was added and incubated for 30 min at 37°C. After six washes, 0.1 ml of tetramethylbenzidine substrate (Sigma) was added for 30 min at 37°C. Reactions were stopped by addition of 25 μl of 2 M H2SO4, and the optical density was determined at 450 nm.

Statistics.The unpaired two-tailed Student ttest was performed with STATVIEW software. P values of <0.05 were considered significant.

RESULTS

Course of infection in C57BL/6 mice.To determine the course of infection with B. henselae strain Berlin-1 in mice, C57BL/6 mice were injected i.p. with 1 × 108 to 2 × 108 CFU ofB. henselae/ml or PBS. At various time points p.i., three animals per group were euthanized and organs were analyzed for recovery of B. henselae by culture and PCR. Bacteria could be cultivated during the first 3 days p.i. from livers and up to 6 days p.i. from spleens (data not shown). Thus, the kinetics of clearance of viable bacteria from organs was similar to the one described previously by us (22) for B. henselae strain Houston-1.

Liver tissue was also subjected to PCR amplification of thehtrA gene (1). Here, Bartonella DNA could be detected in livers of infected animals up to 12 weeks p.i. (Table1), while all tissue samples from PBS-injected control animals revealed negative results (not shown). These findings suggest that, despite our failing to cultivate B. henselae from livers of infected mice beyond the first week p.i., bacterial antigens might persist in the liver tissue for several weeks p.i.

View this table:
  • View inline
  • View popup
Table 1.

Detection of B. henselae DNA by amplification of the htrA gene in liver tissue of B. henselae-infected mice

Histopathological lesions in livers of infected mice. B. henselae strains have previously been shown to be able to induce inflammatory lesions during experimental infections of mice and cats (9, 21, 22). To further characterize the infection of mice with B. henselae strain Berlin-1, liver tissue from infected and uninfected mice was analyzed for histopathological alterations at various time points p.i. Only in liver tissues of infected mice could mononuclear cell infiltrations already be detected at 2 weeks p.i. (Fig. 1A). The lesions expanded in size and number continuously and reached maximal density at 12 weeks p.i. (Fig. 2). They consisted mainly of lymphocytes and monocytes and were located in both perivascular (Fig.1A) and intraparenchymal (Fig. 1B) regions. Although the size and number of the inflammatory foci decreased thereafter, some lesions were still detectable at the latest time point of observation, i.e., at 20 weeks p.i. (Fig. 2). Hence, the Berlin-1 strain induces a long-lived inflammatory reaction in the liver tissue of immunocompetent C57BL/6 mice.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Granulomatous lesion in the liver tissue of B. henselae-infected mice. C57BL/6 mice were infected i.p. with 2 × 108 CFU of B. henselae for 2 (A) or 12 weeks (B). Sections were stained with hematoxylin and eosin. Original magnification, ×400.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Kinetics of cellular inflammatory reactions in the livers of B. henselae-infected mice. C57BL/6 mice were injected i.p. with 2 × 108 CFU of B. henselae or PBS. At indicated time points, five animals per group were euthanized, liver tissue was stained for histology with hematoxylin and eosin, and lesions were counted. Results are presented as means ± standard errors.

T-cell responses. (i) Proliferative responses of spleen cells.To determine the cell-mediated immune responses induced by B. henselae, we investigated the proliferative responses of spleen cells from infected and uninfected mice upon in vitro stimulation with HKBH at 8 weeks p.i. Spleen cells of infected mice proliferated in a dose-dependent manner after stimulation with HKBH, while splenocytes of uninfected mice revealed very low proliferation rates (Fig.3). The proliferative responses of splenocytes from infected mice were significantly higher (P < 0.05) than those from uninfected mice upon stimulation with HKBH at concentrations of 105 to 107 CFU/ml. Thus, B. henselaeinfection induces significant T-cell responses in vivo, which are detectable in vitro by means of spleen cell proliferation assays.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Proliferative responses of spleen cells from B. henselae-infected mice. C57BL/6 mice were injected i.p. with 2 × 108 CFU of B. henselae or PBS. At 8 weeks p.i., four animals per group were euthanized and spleen cells were isolated. Splenocytes were stimulated in vitro with 104 to 107 CFU of HKBH/ml or medium for 3 days, and proliferation was determined by [3H]TdR uptake. Results are means ± standard errors. Single asterisk,P < 0.05; double asterisks, P< 0.001.

(ii) Role of CD4+ T cells in proliferative responses toB. henselae.To further determine the T-cell subset(s) which substantially contributes to the proliferative responses of splenocytes to Bartonella antigens, anti-CD4 and anti-CD8 antibodies were added to the spleen cell cultures prior to stimulation with HKBH. Administration of anti-CD4, but not of anti-CD8 or an isotype-matched control MAb, resulted in a more-than-60% reduction of proliferation of splenocytes from infected mice (Fig.4), indicating that CD4+ T cells play a key role in CMI induced byB. henselae.

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Proliferative responses of splenocytes from infected mice in the presence of anti-CD4 or anti-CD8 antibodies. C57BL/6 mice were infected i.p. with 2 × 108 CFU of B. henselae for 8 weeks. Spleen cells were stimulated with 106 CFU of HKBH/ml for 3 days in the presence of 20 μg of MAbs against CD4, CD8, or an isotype-matched control/ml or in the absence of antibodies. Results represent mean counts per minute ± standard errors (three animals). The mean spontaneous proliferation rate without stimulation was 11,170 ± 2,708 cpm.

(iii) Kinetics of the Bartonella-specific proliferative responses.To evaluate the development of cell-mediated immune responses, we decided to monitor the proliferative responses at various time points after infection. Splenocytes were isolated at 2 to 20 weeks p.i. and stimulated with HKBH, mitogens, or medium only. After 2 weeks of infection, splenocytes from infected mice revealed very high proliferation rates upon stimulation with HKBH, compared to those from uninfected animals (Table2). However, at this time, the spontaneous proliferation in the absence of the antigen was also significantly higher for infected mice than for uninfected animals (Table 2). Thus, the early time point (2 weeks p.i.) does not seem to be appropriate for the analysis of Bartonella-specific CMI by means of the spleen cell proliferation assay because of high background proliferation. In contrast, at all later time points of observation, i.e., between 4 to 20 weeks p.i., the proliferative responses of splenocytes from infected and uninfected mice to stimulation with mitogens or medium were comparable (not shown). At those time points, splenocytes from infected animals revealed significantly higher proliferative responses upon stimulation with HKBH than those from uninfected mice. To facilitate comparison of the proliferative responses at different time points p.i., SRs were determined. As shown in Fig. 5, theBartonella-specific SRs increased continuously from the 2nd week p.i., reaching a maximum at 8 weeks p.i. and decreasing thereafter. Therefore, the most appropriate time for the analysis ofBartonella-specific CMI by means of a lymphoproliferation assay is at about 8 weeks p.i.

View this table:
  • View inline
  • View popup
Table 2.

Proliferative responses of splenocytes from B. henselae-infected and uninfected mice at 2 weeks p.i.

Fig. 5.
  • Open in new tab
  • Download powerpoint
Fig. 5.

Kinetics of Bartonella-specific proliferation of spleen cells from infected mice. Spleen cell proliferation assays were performed as described for Fig. 3. SIs were calculated by dividing the mean counts per minute of wells (triplicates) containing antigen (HKBH at the indicated concentrations) by the mean counts per minute for wells without antigen. SRs were calculated by dividing the SI of each infected mouse by the mean SI of three uninfected control mice tested simultaneously. Results represent mean counts per minute ± standard errors.

(iv) IFN-γ production by spleen cells of infected mice.The Th phenotypes of CD4+ T cells involved in CMI induced by an infectious agent can be differentiated by their cytokine secretion patterns. CD4+ T cells of the Th1 type predominantly produce IFN-γ, while Th2 cells secrete large amounts of IL-4 and IL-5. We therefore investigated the secretion of IFN-γ and IL-4 by spleen cells of B. henselae-infected mice after in vitro stimulation with HKBH. Only spleen cells from infected mice responded in a dose-dependent manner to stimulation with HKBH by secretion of IFN-γ (Fig. 6). Although we noticed considerable variation among animals within the infected group, the difference in IFN-γ production was statistically significant (P < 0.05) at high antigen concentrations, i.e., at HKBH concentrations of 106 and 107 CFU/ml. In contrast, IL-4 was not detectable in the supernatants of spleen cells from infected and uninfected mice upon stimulation with HKBH (detection limit, 150 pg/ml). These data suggest that B. henselae predominantly induces Th1 type responses in C57BL/6 mice.

Fig. 6.
  • Open in new tab
  • Download powerpoint
Fig. 6.

IFN-γ secretion by spleen cells from B. henselae-infected mice. C57BL/6 mice were injected i.p. with 2 × 108 CFU of B. henselae or PBS. At 12 weeks p.i., five animals per group were euthanized and spleens were collected. Spleen cells were stimulated in vitro for 48 h with 104 to 107 CFU of HKBH/ml or medium only, and IFN-γ release was determined by ELISA. Results are means ± standard errors. Asterisk, P < 0.05.

Antibody responses. (i) Production ofBartonella-specific IgG antibodies.Antibody responses to infection with B. henselae were monitored by OMP ELISA for detection of serum IgG antibodies. As shown in Fig.7, Bartonella-specific IgG was detected in serum samples of infected mice from 2 weeks p.i. through the whole period of observation. The levels of B. henselae-specific IgG peaked at 12 weeks p.i.

Fig. 7.
  • Open in new tab
  • Download powerpoint
Fig. 7.

Production of B. henselae-specific IgG antibodies in infected mice. C57BL/6 mice were injected i.p. with 2 × 108 CFU of B. henselae or PBS. At indicated time points, five animals per group were euthanized and serum samples were subjected to OMP ELISA. Results are means ± standard errors. OD 450, optical density at 450 nm.

(ii) Characterization of IgG isotypes amongBartonella-specific antibodies.In mice, IgG1 and IgE have been shown to be associated with a Th2 type response, whereas IgG2a and IgG2b are associated with Th1 type cell-mediated immune responses (20). We were therefore interested in the Th pattern of IgG isotypes in B. henselae-infected mice. Serum samples from mice infected for 4 weeks with B. henselae were serially diluted and subjected to the OMP ELISA to determine theBartonella-specific total IgG, IgG1, and IgG2b antibodies. The levels of Bartonella-specific IgG2b were found to be markedly higher than those of IgG1 (Fig.8), further supporting the induction of Th1 type responses by B. henselae in C57BL/6 mice.

Fig. 8.
  • Open in new tab
  • Download powerpoint
Fig. 8.

Analysis of IgG isotypes amongBartonella-specific serum antibodies in infected mice. C57BL/6 mice were infected i.p. with 2 × 108 CFU ofB. henselae for 4 weeks. Serum samples were serially diluted and analyzed by OMP ELISA. Results are means ± standard errors (five animals per group). OD 450, optical density at 450 nm.

DISCUSSION

The aim of the present study was to characterize the immune responses induced by B. henselae in the immunocompetent murine host in order to improve the understanding of the pathogenesis and immunological control of this infection. We used a murine infection model established in our laboratory (22) and choseB. henselae isolate Berlin-1, which was recently isolated by our group (4) and which therefore had not been subjected to multiple in vitro or in vivo passages, for this study.

The course of infection was similar to the course that we previously observed for the Houston-1 strain (22). Viable bacteria were cleared within 1 week from organs of infected mice, whileBartonella DNA remained detectable for up to 12 weeks p.i., suggesting that bacterial antigens might persist for a long time in the infected host and stimulate its immune system. Differences regarding the kinetics of the granulomatous inflammation in the liver were observed. In the present study, the lesions peaked later, reached a lower absolute number, and persisted longer. This was most likely due to differences in the virulence of the B. henselae strains, since the mouse strain, the route of infection, and the infectious dose were identical.

Little is known so far about differences in virulence amongB. henselae strains; however, recent data from human and feline infections point to possible differences (3, 6, 21). Interestingly, the Berlin-1 strain and the Houston-1 strain have been shown to be indistinguishable by means of pulsed-field gel electrophoresis analysis and 16S rRNA typing (3, 4), suggesting that these isolates might be genetically identical. Given this, it appears to be likely that multiple passages of the Houston-1 strain might have led to a down-regulation of virulence factors in this strain. Accordingly, Batterman et al. (5) reported that multiple passages of B. henselae led to a loss of pilus expression by the bacteria, which was associated with reduced adhesion to and entry into epithelial cells. Hence, our data indicate that the primary isolate of a human-derived B. henselae strain induces a chronic inflammation in the livers of immunocompetent mice and might therefore be useful for future studies on chronicBartonella infection.

The role of CMI in the pathogenesis and control of murine B. henselae infection is poorly understood, and the T-cell subsets involved in cell-mediated immune responses of mice against B. henselae have not been characterized. Therefore, we studied the cell-mediated immune responses of infected mice in splenocyte proliferation and cytokine release assays and analyzed the IgG isotypes of the Bartonella-specific antibody responses. Induction of Bartonella-specific T cells by B. henselae in C57BL/6 mice could be demonstrated by means of a spleen cell proliferation assay. The Bartonella-specific proliferative responses were shown to be mainly mediated by CD4+ T cells.

We further studied the kinetics of proliferative responses in order to determine the time point of maximal cellular immune responses against B. henselae. At the earliest time point of investigation, i.e., after 2 weeks of infection, splenocytes from infected animals revealed high proliferative responses upon stimulation with HKBH. However, significant differences between infected and uninfected animals were also seen in the absence of B. henselae antigens. Therefore, the proliferative responses at this early phase of infection were not considered specific for HKBH. A possible explanation for this finding might include the in vivo stimulatory effect of the inoculated bacteria on the lymphocytes of infected mice, which might still be detectable in vitro at 2 weeks p.i. In contrast, we did not find any high background proliferation at the later time points p.i., i.e., at 4 weeks or thereafter. Comparison of proliferative responses at different time points revealed thatBartonella-specific proliferation increased continuously from the 2nd week p.i., peaked by 8 weeks, and decreased slowly thereafter. Therefore, about 8 weeks p.i. appears to be the most appropriate time point to study Bartonella-induced cell-mediated immune responses.

In cytokine release assays, Bartonella-specific secretion of IFN-γ, but not IL-4, by spleen cells from infected animals was demonstrated, while none of these cytokines were produced by splenocytes from uninfected mice. Recently, Karem et al. (10) showed that spleen cells from BALB/c mice secreted large amounts of IFN-γ upon in vitro stimulation with B. henselae antigen. However, this was observed regardless of prior exposure of the animals to B. henselae. The induction of nonspecific cell-mediated immune responses in murine spleen cell cultures stimulated with Helicobacter felis(18) or Listeria monocytogenes(17) antigens has previously been found. In contrast, our results demonstrate a Bartonella-specific IFN-γ secretion that was restricted to spleen cells from B. henselae-infected mice. Therefore, B. henselae induces CD4+, IFN-γ-secreting T cells in infected C57BL/6 mice, indicative of a predominantly Th1 type response.

In an attempt to further confirm the Th1 type ofBartonella-specific immune responses in C57BL/6 mice, we determined the IgG isotype pattern of theBartonella-specific serum antibodies. We found that IgG2b rather than IgG1 was the predominant isotype among theBartonella-specific serum IgG antibodies. Therefore, both cytokine secretion and IgG isotype patterns indicate thatBartonella-specific cell-mediated immune responses in C57BL/6 mice display a predominantly Th1 phenotype. Induction of Th1 type immune responses has been shown for other intracellular pathogens including Leishmania (26), Listeria(17), and, more recently, Ehrlichia spp. (15).

Analysis of the kinetics of Bartonella-induced inflammatory lesions, Bartonella-specific proliferative responses, and specific antibody production revealed that the peak of proliferation preceded maximal inflammation in the liver as well as the highest titers of Bartonella-specific antibodies. This underlines a clonal expansion of Bartonella-specific CD4+ T cells as a prerequisite for both the attraction and activation of mononuclear phagocytes for granuloma formation, as well as T helper functions for B-cell stimulation.

In conclusion, our study demonstrates that a human-pathogenic strain ofB. henselae induces a long-lived inflammation in livers of immunocompetent C57BL/6 mice. Concomitantly, B. henselaeelicits cell-mediated immune responses in infected animals that are mainly mediated by CD4+ Th1 cells. These data contribute to the understanding of the pathogenesis and control ofBartonella infection in the immunocompetent murine host and should be helpful for further animal studies, e.g., under conditions of immunosuppression.

ACKNOWLEDGMENTS

We thank Dagmar Piske and Antje Finke for excellent technical assistance.

Notes

Editor: J. D. Clements

FOOTNOTES

    • Received 16 March 2001.
    • Returned for modification 4 May 2001.
    • Accepted 15 June 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson B.,
    2. Sims K.,
    3. Regnery R.,
    4. Robinson L.,
    5. Schmidt M. J.,
    6. Goral S.,
    7. Hager C.,
    8. Edwards K.
    Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR.J. Clin. Microbiol.321994942948
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Anderson B. E.,
    2. Neuman M. A.
    Bartonella spp. as emerging human pathogens.Clin. Microbiol. Rev.101997203219
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Arvand M.,
    2. Klose A. J.,
    3. Schwartz-Porsche D.,
    4. Hahn H.,
    5. Wendt C.
    Genetic variability and prevalence of Bartonella henselae in cats in Berlin, Germany, and analysis of its genetic relatedness to a strain from Berlin that is pathogenic for humans.J. Clin. Microbiol.392001743746
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Arvand M.,
    2. Wendt C.,
    3. Regnath T.,
    4. Ullrich R.,
    5. Hahn H.
    Characterization of Bartonella henselae isolated from bacillary angiomatosis lesions in a human immunodeficiency virus-infected patient in Germany.Clin. Infect. Dis.26199812961299
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Batterman H. J.,
    2. Peek J. A.,
    3. Loutit J. S.,
    4. Falkow S.,
    5. Tompkins L. S.
    Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells.Infect. Immun.63199545534556
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Bergmans A. M.,
    2. Schellekens J. F.,
    3. van Embden J. D.,
    4. Schouls L. M.
    Predominance of two Bartonella henselae variants among cat scratch disease patients in The Netherlands.J. Clin. Microbiol.341996254260
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Chomel B. B.,
    2. Kasten R. W.,
    3. Floyd H. K.,
    4. Chi B.,
    5. Yamamoto K.,
    6. Roberts W. J.,
    7. Gurfield A. N.,
    8. Abbott R. C.,
    9. Pedersen N. C.,
    10. Koehler J. E.
    Experimental transmission of Bartonella henselae by the cat flea.J. Clin. Microbiol.34199619521956
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Delahoussaye P. M.,
    2. Osborne B. M.
    Cat-scratch disease presenting as abdominal visceral granulomas.J. Infect. Dis.16119907178
    OpenUrlCrossRefPubMedWeb of Science
  9. 8a.↵
    1. Fuhrmann O.,
    2. Arvand M.,
    3. Gohler A.,
    4. Schmid M.,
    5. Krull M.,
    6. Hippenstiel S.,
    7. Seybold J.,
    8. Dehio C.,
    9. Suttorp N.
    Bartonella henselae induces NF-kappaB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors.Infect. Immun.69200150885097
    OpenUrlAbstract/FREE Full Text
  10. 9.↵
    1. Guptill L.,
    2. Slater L.,
    3. Wu C. C.,
    4. Lin T. L.,
    5. Glickman L. T.,
    6. Welch D. F.,
    7. HogenEsch H.
    Experimental infection of young specific pathogen-free cats with Bartonella henselae.J. Infect. Dis.1761997206216
    OpenUrlCrossRef
  11. 10.↵
    1. Karem K. L.,
    2. Dubois K. A.,
    3. McGill S. L.,
    4. Regnery R. L.
    Characterization of Bartonella henselae-specific immunity in BALB/c mice.Immunology971999352358
    OpenUrlCrossRefPubMedWeb of Science
  12. 11.↵
    1. Kordick D. L.,
    2. Brown T. T.,
    3. Shin K.,
    4. Breitschwerdt E. B.
    Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.J. Clin. Microbiol.37199915361547
    OpenUrlAbstract/FREE Full Text
  13. 12.↵
    1. Lamps L. W.,
    2. Gray G. F.,
    3. Scott M. A.
    The histologic spectrum of hepatic cat scratch disease. A series of six cases with confirmed Bartonella henselae infection.Am. J. Surg. Pathol.20199612531259
    OpenUrlCrossRefPubMedWeb of Science
  14. 13.↵
    1. Lenoir A. A.,
    2. Storch G. A.,
    3. DeSchryver K. K.,
    4. Shackelford G. D.,
    5. Rothbaum R. J.,
    6. Wear D. J.,
    7. Rosenblum J. L.
    Granulomatous hepatitis associated with cat scratch disease.Lanceti198811321136
    OpenUrl
  15. 14.↵
    1. Margileth A. M.
    Cat scratch disease and nontuberculous mycobacterial disease: diagnostic usefulness of PPD-Battey, PPD-T and cat scratch skin test antigens.Ann. Allergy681992149154
    OpenUrlPubMedWeb of Science
  16. 15.↵
    1. Martin M. E.,
    2. Bunnel J. E.,
    3. Dumler J. S.
    Pathology, immunhistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model.J. Infect. Dis.1812000374378
    OpenUrlCrossRefPubMedWeb of Science
  17. 16.↵
    1. Mielke M. E.,
    2. Autenrieth I. B.,
    3. Held T. K.
    The immune response in mice challenged with bacterial infections.Methods Microbiol.251998313364
    OpenUrl
  18. 17.↵
    1. Mielke M. E.,
    2. Peters C.,
    3. Hahn H.
    Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis.Immunol. Rev.15819977993
    OpenUrlCrossRefPubMedWeb of Science
  19. 18.↵
    1. Mohammadi M.,
    2. Czinn S.,
    3. Redline R.,
    4. Nedrud J.
    Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.J. Immunol.156199647294738
    OpenUrlAbstract
  20. 19.↵
    1. Mohle-Boetani J. C.,
    2. Koehler J. E.,
    3. Berger T. G.,
    4. LeBoit P. E.,
    5. Kemper C. A.,
    6. Reingold A. L.,
    7. Plikaytis B. D.,
    8. Wenger J. D.,
    9. Tappero J. W.
    Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study.Clin. Infect. Dis.221996794800
    OpenUrlCrossRefPubMed
  21. 20.↵
    1. Mountford A. P.,
    2. Hogg K. G.,
    3. Coulson P. S.,
    4. Brombacher F.
    Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice.Infect. Immun.692001228236
    OpenUrlAbstract/FREE Full Text
  22. 21.↵
    1. O'Reilly K. L.,
    2. Bauer R. W.,
    3. Freeland R. L.,
    4. Foil L. D.,
    5. Hughes K. J.,
    6. Rohde K. R.,
    7. Roy A. F.,
    8. Stout R. W.,
    9. Triche P. C.
    Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16).Infect. Immun.67199930663072
    OpenUrlAbstract/FREE Full Text
  23. 22.↵
    1. Regnath T.,
    2. Mielke M. E.,
    3. Arvand M.,
    4. Hahn H.
    Murine model of Bartonella henselae infection in the immunocompetent host.Infect. Immun.66199855345536
    OpenUrlAbstract/FREE Full Text
  24. 23.↵
    1. Regnery R. L.,
    2. Rooney J. A.,
    3. Johnson A. M.,
    4. Nesby S. L.,
    5. Manzewitsch P.,
    6. Beaver K.,
    7. Olson J. G.
    Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats.Am. J. Vet. Res.57199617141719
    OpenUrlPubMed
  25. 24.↵
    1. Schwartzman W. A.,
    2. Nesbit C. A.,
    3. Baron E. J.
    Development and evaluation of a blood-free medium for determining growth curves and optimizing growth of Rochalimaea henselae.J. Clin. Microbiol.31199318821885
    OpenUrlAbstract/FREE Full Text
  26. 25.↵
    1. Slater L. N.,
    2. Coody D. W.,
    3. Woolridge L. K.,
    4. Welch D. F.
    Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana.J. Clin. Microbiol.30199217221727
    OpenUrlAbstract/FREE Full Text
  27. 26.↵
    1. Wang Z. E.,
    2. Reiner S. L.,
    3. Zheng S.,
    4. Dalton D. K.,
    5. Locksley R. M.
    CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major.J. Exp. Med.179199413671371
    OpenUrlAbstract/FREE Full Text
  28. 27.↵
    1. Wear D. J.,
    2. Margileth A. M.,
    3. Hadfield T. L.,
    4. Fischer G. W.,
    5. Schlagel C. J.,
    6. King F. M.
    Cat scratch disease: a bacterial infection.Science221198314031405
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Bartonella henselae-Specific Cell-Mediated Immune Responses Display a Predominantly Th1 Phenotype in Experimentally Infected C57BL/6 Mice
Mardjan Arvand, Ralf Ignatius, Thomas Regnath, Helmut Hahn, Martin E. A. Mielke
Infection and Immunity Oct 2001, 69 (10) 6427-6433; DOI: 10.1128/IAI.69.10.6427-6433.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Bartonella henselae-Specific Cell-Mediated Immune Responses Display a Predominantly Th1 Phenotype in Experimentally Infected C57BL/6 Mice
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Bartonella henselae-Specific Cell-Mediated Immune Responses Display a Predominantly Th1 Phenotype in Experimentally Infected C57BL/6 Mice
Mardjan Arvand, Ralf Ignatius, Thomas Regnath, Helmut Hahn, Martin E. A. Mielke
Infection and Immunity Oct 2001, 69 (10) 6427-6433; DOI: 10.1128/IAI.69.10.6427-6433.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Angiomatosis, Bacillary
Th1 Cells

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522